Recent Insider Transactions - Atai Life Sciences (NASDAQ: ATAI)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ ATAI Atai Life Sciences

Short Glenn Frank / officer: Chief Scientific Officer

03/03/2025

Buy

$1.50

757,915

$1.137M

757,915

NASDAQ ATAI Atai Life Sciences

Craig Kevin James / officer: Chief Medical Officer

03/03/2025

Buy

$1.50

757,915

$1.137M

757,915

NASDAQ ATAI Atai Life Sciences

Johnson Anne Nagengast / officer: Chief Financial Officer

03/03/2025

Buy

$1.50

757,915

$1.137M

757,915

NASDAQ ATAI Atai Life Sciences

Apeiron Investment Group Ltd. / 10 percent owner

02/14/2025

Buy

$2.10

10.84M

$22.755M

40.56M